Yamaguchi J, Yokoyama Y, Fujii T, Yamada S, et al. Results of a Phase II Study on the use of Neoadjuvant Chemotherapy (FOLFIRINOX or Gemcitabine with nab-paclitaxel) for Borderline-Resectable Pancreatic Cancer (NUPAT-01). Ann Surg 2022 Mar 3. pii: 00000658-900000000-93060.
PMID: 35258510